Gerstein Fisher’s Teva Pharmaceuticals TEVA Stock Holding History

Gerstein Fisher’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,443	Closed	-$256K	–	415
2014 Q4	$256K	Buy	+4,443	New	+$248K	0.04%	322

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Gerstein Fisher's TEVA Position: Q1 2015 in Review

Gerstein Fisher sold out of Teva Pharmaceuticals (TEVA) in Q1 2015, closing a stake of 4,443 shares — an estimated $256K sold.

Gerstein Fisher first reported a position in TEVA in Q4 2014 and held it in 1 quarter. The position peaked at $256K in Q4 2014. 821 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

Gerstein Fisher reported no remaining Teva Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Gerstein Fisher sold 4,443 Teva Pharmaceuticals shares in Q1 2015, an estimated $256K.
Gerstein Fisher first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 1 quarter.
Gerstein Fisher's Teva Pharmaceuticals position peaked at $256K in Q4 2014.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Gerstein Fisher's 13F filing for Q1 2015, filed 14 May 2015.